MHRA Marketing Authorisations Granted 1 to 14 January 2024 MHRA granted one OTC license in January 2024. MHRA Marketing Authorisations Granted 1 to 14 January 2024
EMA HMPC Questions & Answers on Quality of Herbal Medicinal Products – Revision 7 EMA Committee on Herbal Medicinal Products (HMPC) has published the revised questions & answers on quality of herbal medicinal products/traditional herbal medicinal products. EMA HMPC Questions & Answers on Quality of Herbal Medicinal Products – Revision 7
CMDh January 2024 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published the report from the CMDh meeting held on 23-25 January. CMDh January 2024 Meeting – Report
HMA Meetings – September and December 2023 Heads of Medicines Agencies (HMA) has published the minutes of its 113th and 114th meetings. HMA Meetings – September and December 2023
EMA PRAC Work Plan 2024 The European Medicines Agency (EMA) has published the Pharmacovigilance Risk Assessment Committee (PRAC) Work Plan 2024 which was adopted by the Committee on 26 January 2024. EMA PRAC Work Plan 2024
EU 101st Pharmaceutical Committee Meeting – 23 November 2023 The summary record of the 101st meeting of the Pharmaceutical Committee that took place on 23 November 2023 has been published. EU 101st Pharmaceutical Committee Meeting – 23 November 2023
MHRA Performance Data for Assessment of Clinical Trials and Established Medicines MHRA has published MHRA performance metrics for clinical trials and established medicines assessment. MHRA Performance Data for Assessment of Clinical Trials and Established Medicines
EMA Q&A Document on Article 5(3) of Regulation (EC) 726/2004 – Nitrosamine Impurities in Medicines EMA has updated the Q&A document related to nitrosamine impurities in medicinal products. EMA Q&A Document on Article 5(3) of Regulation (EC) 726/2004 – Nitrosamine Impurities in Medicines
Border Target Operating Model (BTOM) material The Cabinet Office has published useful material on BTOM. Border Target Operating Model (BTOM) material
MHRA Launches New Fees Calculator MHRA has developed a fees calculator to help companies calculate the fees they will be charged when making an initial or a variation application for a medicinal product. MHRA Launches New Fees Calculator
NHS Standard Contract 2024/25 Consultation NHSE has published the draft 2024/25 NHS Standard Contract for consultation. The consultation paper describes the main, material changes being proposed in the Contracts. NHSE welcome comments from stakeholders and Industry on the proposals. NHS Standard Contract 2024/25 Consultation
MHRA Publishes Marketing Authorisations Granted 15 December to 31 December 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has published the list of marketing authorisations granted during 15 - 31 December 2023, which includes four GSL licences. MHRA Publishes Marketing Authorisations Granted 15 December to 31 December 2023